Intellectia LogoIntellectia
Product
Resources
Markets
News
Partner Program
Pricing
Log inTry for Free
Intellectia Logo
Log in
Intellectia Logo

Product

Features
Financial AI Agent
Stock Technical Analysis
Stock Monitor
Hedge Fund Tracker
AI Screener
Trading Strategies
AI Stock Picker
Swing Trading
Quant AI
Stock Chart Patterns
Daytrading Center
AI Earnings Prediction
Whales Auto Tracker
Backtesting Playground

Resources

Learn
Blog
Earnings
Tutorial
Help Center
Company
About Us
Contact
Press
Reward Program
Partner Program
Tools
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Compare
TradingView
SeekingAlpha

Markets

Trending Stocks
Hot Crypto
Trending News
All Stocks

News

Trading News
Overview
Top News
Daily Market Brief
Earnings
Latest
Newswire
Stock News
Crypto News
Monitor News
Partner ProgramPricing
Start for Free
  1. Home
    2. >
  2. Stock
    3. >
  3. CLOV
stocks logo

CLOV

-
collectAdd to Watchlistadvanced chartAdvanced Chart
$
0.000
0(0.000%)1D
collectadvanced chart
    Overview
    Forecast
    Valuation
    Earnings
High
--
Open
--
VWAP
--
Vol
--
Mkt Cap
--
Low
--
Amount
--
EV/EBITDA(TTM)
--
Total Shares
--
EV
--
EV/OCF(TTM)
--
P/S(TTM)
--
AI Stock Picker
AI Stock Picker

Market Estimates

Earnings Estimates
Earnings Estimates
Revenue
YoY Chg
EPS
YoYChg
FY2025Q4
FY2026Q1
FY2026Q2
467.06M
+38.61%
-0.102
+155.3%
650.52M
+40.7%
0.007
-341%
667.07M
+39.66%
0.014
-168.05%
Estimates Revision
The market is revising Upward the revenue expectations for Clover Health Investments, Corp. (CLOV) for FY2025, with the revenue forecasts being adjusted by 1.26% over the past three months. During the same period, the stock price has changed by -3.27%.
Revenue Estimates for FY2025
Revise Upward
up Image
+1.26%
In Past 3 Month
EPS Estimates for FY2025
Revise Upward
up Image
+52.71%
In Past 3 Month
Stock Price
Go Down
down Image
-3.27%
In Past 3 Month
Wall Street analysts forecast CLOV stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for CLOV is 3.35 USD with a low forecast of 3.00 USD and a high forecast of 3.70 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
3 Analyst Rating
Wall Street analysts forecast CLOV stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for CLOV is 3.35 USD with a low forecast of 3.00 USD and a high forecast of 3.70 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
2 Buy
1 Hold
0 Sell
Moderate Buy
Current: 2.660
sliders
Low
3.00
Averages
3.35
High
3.70
Current: 2.660
sliders
Low
3.00
Averages
3.35
High
3.70
Canaccord
Buy
downgrade
2025-11-06
Reason
Canaccord
Price Target
2025-11-06
downgrade
Buy
Reason
Canaccord lowered the firm's price target on Clover Health to $3.70 from $4.10 and keeps a Buy rating on the shares. The firm said Clover's return to significant growth during last year's AEP and throughout 2025 when membership in its MA plans expanded rapidly finally caught up to the company in 3Q with a sizable adj-EBITDA miss and downward profitability guidance revision as elevated medical cost trend materialized in the quarter along with prior period development from 1H'25.
Canaccord
Buy
downgrade
2025-08-07
Reason
Canaccord
Price Target
2025-08-07
downgrade
Buy
Reason
Canaccord lowered the firm's price target on Clover Health to $4.10 from $4.50 and keeps a Buy rating on the shares. The firm said they reported solid Q2 results however the insurance benefit expense ration came in higher than expected which created some concern.
Craig-Hallum
Matt Hewitt
Buy
downgrade
$6 -> $5
2025-08-06
Reason
Craig-Hallum
Matt Hewitt
Price Target
$6 -> $5
2025-08-06
downgrade
Buy
Reason
Craig-Hallum analyst Matt Hewitt lowered the firm's price target on Clover Health to $5 from $6 and keeps a Buy rating on the shares. The firm notes the company reported strong revenue and membership growth and maintained adjusted EBITDA and adjusted net income profitability. Despite the otherwise positive update, Craih-Hallum points out that the benefits expense ratio increased for the quarter due to Part D utilization and impacts from the Inflation Reduction Act and that may weigh on the shares.
Canaccord Genuity
Richard Close
Strong Buy
Maintains
$4.2 → $4.5
2025-03-03
Reason
Canaccord Genuity
Richard Close
Price Target
$4.2 → $4.5
2025-03-03
Maintains
Strong Buy
Reason
Craig-Hallum
Matt Hewitt
Strong Buy
Initiates
$6
2024-12-17
Reason
Craig-Hallum
Matt Hewitt
Price Target
$6
2024-12-17
Initiates
Strong Buy
Reason
Craig-Hallum analyst Matt Hewitt initiated coverage of Clover Health with a Buy rating and $6 price target.
See All Ratings

Valuation Metrics

The current forward P/E ratio for Clover Health Investments Corp (CLOV.O) is -33.29, compared to its 5-year average forward P/E of -11.46. For a more detailed relative valuation and DCF analysis to assess Clover Health Investments Corp 's fair value, click here.
  • Forward PE
  • Forward EV/EBITDA
  • Forward PS

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PE
-11.46
Current PE
-33.29
Overvalued PE
-0.08
Undervalued PE
-22.84

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average EV/EBITDA
7.39
Current EV/EBITDA
0.00
Overvalued EV/EBITDA
27.50
Undervalued EV/EBITDA
-12.73

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PS
0.94
Current PS
0.00
Overvalued PS
2.04
Undervalued PS
-0.17
Intellectia AI SwingMax
Intellectia AI SwingMax

Financials

Annual
Quarterly
N/A
Total Revenue
N/A
Operating Profit
N/A
Net Income after Tax
N/A
EPS - Diluted
N/A
Free Cash Flow
N/A
Gross Profit Margin - %
N/A
FCF Margin - %
N/A
Net Margin - %

Trading Trends

  • Insider
  • Hedge Fund
  • Congress Trading
Insider
Insiders areSelling! The selling amount has increased 118.63% over the last month.
Sold
Bought
Hedge Fund
Hedge Funds are Neutral. There are no significant trading trends over the last quarter.
Sold
Bought
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Insider
Insiders areSelling! The selling amount has increased 118.63% over the last month.
Sold
Bought
Financial AI Agent
Financial AI Agent

CLOV News & Events

Events Timeline

(ET)
2025-11-04
16:13:38
Clover Health Reports Robust Economics for Returning Member Cohort in FY26
select
2025-11-04
16:13:08
Clover Health projects adjusted net income of $15M-$30M for FY25
select
2025-11-04
16:12:38
Clover Health Announces Q3 Earnings Per Share of 5 Cents, Exceeding Consensus Estimate of 2 Cents
select
Sign Up For More Events
Sign Up For More Events

News

[object Object]
Preview
8.0
02:00 AMNASDAQ.COM
Significant Options Activity on Thursday: PVH, CLOV, IONQ

  • Clover Health Options Activity: Clover Health Investments Corp (CLOV) experienced significant options trading with 39,482 contracts, equating to about 3.9 million underlying shares, notably for the $3 strike call option expiring December 12, 2025.

  • Ionq Inc Options Activity: Ionq Inc (IONQ) saw a high volume of 132,680 contracts traded, representing approximately 13.3 million underlying shares, particularly for the $35 strike put option expiring December 12, 2025.

  • Trading Volume Comparison: The options trading volumes for both CLOV and IONQ accounted for 56.4% and 55.9% of their respective average daily trading volumes over the past month.

  • Further Information: For additional details on available expirations for various options, including PVH, CLOV, and IONQ, StockOptionsChannel.com can be visited.

[object Object]
Preview
9.5
11-05Benzinga
Super Micro Computer Reports Disappointing Q1 Results, Alongside Pinterest, Axon Enterprise, and Other Major Stocks Declining in Wednesday's Pre-Market Trading

  • U.S. Stock Market Trends: U.S. stock futures are down, with the Dow futures dropping over 50 points, reflecting a negative market sentiment.

  • Super Micro Computer Performance: Super Micro Computer Inc. shares fell 9.2% after reporting disappointing first-quarter earnings of 35 cents per share, missing estimates, and issuing lower second-quarter EPS guidance.

  • Other Notable Stock Declines: Several companies, including Biohaven Ltd and Trex Company Inc, experienced significant pre-market declines, with Biohaven tumbling 46.2% after receiving an FDA Complete Response Letter.

  • Mixed Results from Major Firms: Companies like Axon Enterprise and Pinterest reported mixed third-quarter results, leading to notable drops in their stock prices, with Axon down 19.6% and Pinterest down 18.8%.

[object Object]
Preview
9.5
11-05SeekingAlpha
Clover Health Shares Fall Even After Raising Revenue Forecast

  • Stock Performance: Clover Health's shares fell approximately 20% after the company reported Q3 2025 results, lowering its full-year adjusted EBITDA guidance despite raising its revenue outlook.

  • Revenue Growth: The company achieved better-than-expected revenue of $496.7 million, reflecting a 50% year-over-year growth, with Medicare Advantage memberships increasing by about 35% to over 109,000 members.

  • Financial Challenges: Clover Health's benefit expense ratio increased significantly to 93.5%, and adjusted EBITDA dropped nearly 89% year-over-year to $2.1 million, with a net loss widening to $0.05 per share, missing analyst expectations.

  • Future Projections: The company revised its revenue forecast for 2025 to between $1.850 billion and $1.880 billion but lowered its adjusted EBITDA outlook to $15 million to $30 million, indicating rising cost trends.

Sign Up For More News

People Also Watch

FAQ

arrow icon

What is Clover Health Investments Corp (CLOV) stock price today?

The current price of CLOV is 2.66 USD — it has increased 1.53 % in the last trading day.

arrow icon

What is Clover Health Investments Corp (CLOV)'s business?

Clover Health Investments, Corp. is a physician enablement technology company. The Company is focused on bringing access to healthcare to everyone on Medicare. This includes a health equity-based focus on seniors, who have historically lacked access to affordable healthcare. Its software platform, Clover Assistant, is designed to aggregate patient data from across the healthcare ecosystem to support clinical decision-making and improve health outcomes through the early identification and management of chronic disease. The Company, through its Insurance segment, provides Preferred Provider Organization (PPO) and Health Maintenance Organization (HMO) plans to Medicare Advantage (MA) members in several states, with a differentiated focus on its flagship wide-network, high-choice PPO plans. For healthcare providers outside its MA plan, it focuses on extending the benefits of its data-driven technology platform to a wider audience via its subsidiary, Counterpart Health, Inc.

arrow icon

What is the price predicton of CLOV Stock?

Wall Street analysts forecast CLOV stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for CLOV is 3.35 USD with a low forecast of 3.00 USD and a high forecast of 3.70 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

arrow icon

What is Clover Health Investments Corp (CLOV)'s revenue for the last quarter?

Clover Health Investments Corp revenue for the last quarter amounts to 496.65M USD, increased 50.05 % YoY.

arrow icon

What is Clover Health Investments Corp (CLOV)'s earnings per share (EPS) for the last quarter?

Clover Health Investments Corp. EPS for the last quarter amounts to -0.05 USD, increased 150.00 % YoY.

arrow icon

What changes have occurred in the market's expectations for Clover Health Investments Corp (CLOV)'s fundamentals?

The market is revising Upward the revenue expectations for Clover Health Investments, Corp. (CLOV) for FY2025, with the revenue forecasts being adjusted by 1.26% over the past three months. During the same period, the stock price has changed by -3.27%.
arrow icon

How many employees does Clover Health Investments Corp (CLOV). have?

Clover Health Investments Corp (CLOV) has 570 emplpoyees as of December 05 2025.

arrow icon

What is Clover Health Investments Corp (CLOV) market cap?

Today CLOV has the market capitalization of 1.35B USD.

Intellectia LogoIntellectiaIntellectia LogoIntellectia

Redefine Your Investment Decisions

TwitterTwitterYoutubeYoutubeQuoraQuoraDiscordDiscordLinkedinLinkedinTelegramTelegram
AppStoreGooglePlay

Copyright © 2025 Intellectia.AI. All Rights Reserved.

pci certified logo
Company
HomeContactAbout UsNews Release
Compare
TradingViewSeeking Alpha
Features
Financial AI AgentStock Technical AnalysisStock MonitorHedge Fund TrackerAI ScreenerDaytrading Center
Strategies
AI Stock PickerSwing TradingStock Chart PatternsEarnings TradingDaytrading CenterAI Earnings PredictionQuant AIWhales Auto TrackerBacktesting Playground
Free Tools
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Resource
BlogTutorialEarningsTrending StocksCrypto MarketPartner ProgramTerms of UsePrivacy PolicySecuritySitemap
Start for Free